NEUROSENSE THERAPEUTICS LTD (NRSN)
IL0011809592 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -11.28M | -12.34M | -4.04M | -2.83M | -1.22M | |||
| Depreciation Amortization | 97.00K | 90.00K | 0.00 | 0.00 | 0.00 | |||
| Change In Working Capital | 2.31M | 730.00K | 270.00K | 70.00K | 30.00K | |||
| Other non cash items | 421.00K | 3.94M | 2.23M | 2.06M | 610.00K | |||
| OPERATING CASH FLOW | -8.45M | -7.59M | -1.54M | -700.00K | -580.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -29.00K | -70.00K | -20.00K | -10.00K | -10.00K | |||
| Other Investing Activity | 3.67M | -3.47M | 0.00 | N/A | -20.00K | |||
| INVESTING CASH FLOW | 3.65M | -3.54M | -20.00K | -10.00K | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -80.00K | -80.00K | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 3.98M | 3.87M | 11.10M | 510.00K | 1.42M | |||
| Other Financing Activity | 0.00 | -100.00K | 800.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 3.90M | 3.70M | 11.90M | 510.00K | 1.42M | |||
| Exchange Rate Effect | 8.00K | -90.00K | 20.00K | N/A | N/A | |||
| CHANGE IN CASH | -903.00K | -7.52M | 10.36M | -200.00K | 810.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -8.45M | -7.59M | -1.54M | -700.00K | -580.00K | |||
| Capital Expenditure | -29.00K | -70.00K | -20.00K | -10.00K | -10.00K | |||
| FREE CASH FLOW | -8.48M | -7.66M | -1.56M | -710.00K | -590.00K | |||
All data in USD